These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 15315849)

  • 1. Persistent itching nodules after the fourth dose of diphtheria-tetanus toxoid vaccines without evidence of delayed hypersensitivity to aluminium.
    Netterlid E; Bruze M; Hindsén M; Isaksson M; Olin P
    Vaccine; 2004 Sep; 22(27-28):3698-706. PubMed ID: 15315849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unexpectedly high incidence of persistent itching nodules and delayed hypersensitivity to aluminium in children after the use of adsorbed vaccines from a single manufacturer.
    Bergfors E; Trollfors B; Inerot A
    Vaccine; 2003 Dec; 22(1):64-9. PubMed ID: 14604572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life.
    Knuf M; Habermehl P; Faber J; Bock HL; Sänger R; Bogaerts H; Clemens R; Schuind A; du Prel JB; Schmitt HJ
    Vaccine; 2006 Jul; 24(27-28):5627-36. PubMed ID: 16740348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunisation with aluminium-containing vaccine of a child with itching nodule following previous vaccination.
    Frederiksen MS; Tofte H
    Vaccine; 2004 Nov; 23(1):1-2. PubMed ID: 15519700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Itching nodules and hypersensitivity to aluminium after the use of adsorbed vaccines from SSI.
    Thierry-Carstensen B; Stellfeld M
    Vaccine; 2004 May; 22(15-16):1845. PubMed ID: 15121293
    [No Abstract]   [Full Text] [Related]  

  • 6. Nineteen cases of persistent pruritic nodules and contact allergy to aluminium after injection of commonly used aluminium-adsorbed vaccines.
    Bergfors E; Björkelund C; Trollfors B
    Eur J Pediatr; 2005 Nov; 164(11):691-7. PubMed ID: 16044278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. There is an association between contact allergy to aluminium and persistent subcutaneous nodules in children undergoing hyposensitization therapy.
    Netterlid E; Hindsén M; Björk J; Ekqvist S; Güner N; Henricson KA; Bruze M
    Contact Dermatitis; 2009 Jan; 60(1):41-9. PubMed ID: 19125720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How common are long-lasting, intensely itching vaccination granulomas and contact allergy to aluminium induced by currently used pediatric vaccines? A prospective cohort study.
    Bergfors E; Hermansson G; Nyström Kronander U; Falk L; Valter L; Trollfors B
    Eur J Pediatr; 2014 Oct; 173(10):1297-307. PubMed ID: 24752308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical aluminium patch tests in children with persistent itching postvaccinal nodules.
    Raison-Peyron N; Genillier-Foin N; Bessis D; Milpied B
    Pediatr Dermatol; 2018 Jul; 35(4):531-532. PubMed ID: 29656425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sixty-four children with persistent itching nodules and contact allergy to aluminium after vaccination with aluminium-adsorbed vaccines-prognosis and outcome after booster vaccination.
    Bergfors E; Trollfors B
    Eur J Pediatr; 2013 Feb; 172(2):171-7. PubMed ID: 23052615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Aluminum allergy caused by DTP vaccine].
    Nielsen AO; Kaaber K; Veien NK
    Ugeskr Laeger; 1992 Jun; 154(27):1900-1. PubMed ID: 1509548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.
    Gustafsson L; Hessel L; Storsaeter J; Olin P
    Pediatrics; 2006 Sep; 118(3):978-84. PubMed ID: 16950988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of reactivity to a metallic disc and 2% aluminium salt in 366 children, and reproducibility over time for 241 young adults with childhood vaccine-related aluminium contact allergy.
    Gente Lidholm A; Inerot A; Gillstedt M; Bergfors E; Trollfors B
    Contact Dermatitis; 2018 Jul; 79(1):26-30. PubMed ID: 29572857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases
    Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse reactions after diphtheria-tetanus booster in 10-year-old schoolchildren in relation to the type of vaccine given for the primary vaccination.
    Blennow M; Granström M; Strandell A
    Vaccine; 1994 Apr; 12(5):427-30. PubMed ID: 8023551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aluminum allergy following vaccination should be entitled to compensation as drug-induced injury].
    Trollfors B; Bergfors E
    Lakartidningen; 2007 May 9-15; 104(19):1533-4; author reply 1534. PubMed ID: 17550036
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
    Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
    Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term clinical course and prognosis of vaccine-related persistent itching nodules (1997-2019): An observational study.
    Lidholm AG; Inerot A; Gillstedt M; Bergfors E; Trollfors B
    Vaccine X; 2022 Aug; 11():100163. PubMed ID: 35600985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-vaccination aluminium granulomas in children.
    Ravndal L; Bergfors E; Behzadi M; Barstad B; Steinkjer B; Kjosavik S
    Tidsskr Nor Laegeforen; 2022 Mar; 142(4):. PubMed ID: 35239278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age.
    Nolan T; Bernstein H; Blatter MM; Bromberg K; Guerra F; Kennedy W; Pichichero M; Senders SD; Trofa A; Collard A; Sullivan DC; Descamps D
    Pediatrics; 2006 Sep; 118(3):e602-9. PubMed ID: 16950952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.